Benitec Biopharma Income Statement

Financials in millions AUD. Fiscal year is July - June.

Millions AUD. Fiscal year is Jul - Jun.

Year	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014
Revenue	0.08	0.07	0.06	0.1	12.2	3.11	7.56	2.83	2.77	0.42
Revenue Growth (YoY)	2.74%	23.73%	-42.16%	-99.16%	291.99%	-58.81%	167.39%	2.06%	564.21%	-
Gross Profit	0.08	0.07	0.06	0.1	12.2	3.11	7.56	2.83	2.77	0.42
Selling, General & Admin	6.38	6.65	6.51	5.57	4.61	5.37	5.69	6.6	4.37	3.02
Research & Development	12.77	11.27	7.02	3	4.57	4.8	4.83	9.26	4.34	2.62
Other Operating Expenses	0	0.01	0.12	-0.19	0.44	1.16	1	3.95	2.08	-0.07
Operating Expenses	19.16	17.93	13.66	8.38	9.62	11.33	11.51	19.81	10.79	5.56
Operating Income	-19.08	-17.85	-13.6	-8.28	2.58	-8.22	-3.96	-16.98	-8.02	-5.15
Interest Expense / Income	0.03	0.03	0.01	-0.06	0	0	0	0	0	0
Other Expense / Income	0.45	0.32	0.28	0.06	-0.03	-0.11	0.01	0.29	-	0.08
Pretax Income	-19.56	-18.21	-13.88	-8.27	2.61	-8.11	-3.97	-17.27	-8.02	-5.22
Income Tax	0	0	0	0	0	0	0	0	0	-0.32
Net Income	-19.56	-18.21	-13.88	-8.27	2.61	-8.11	-3.97	-17.27	-8.02	-4.91
Shares Outstanding (Basic)	1	0	0	0	0	0	0	0	0	-
Shares Outstanding (Diluted)	1	0	0	0	0	-	-	-	-	-
Shares Change	188.30%	90.24%	320.63%	19.19%	-16.47%	40.00%	26.45%	-	-	-
EPS (Basic)	-0.14	-0.38	-0.55	-1.38	0.52	-131.05	-76.78	-412.58	-236.03	-184.37
EPS (Diluted)	-0.14	-0.38	-0.55	-1.38	0.52	-131.05	-76.78	-412.58	-236.03	-184.37
Free Cash Flow	-18.01	-15.91	-13.05	-7.63	4.39	-6.88	-5.91	-14.32	-7.11	-6.48
Free Cash Flow Per Share	-13.00	-33.10	-51.66	-127.00	87.11	-114.08	-137.06	-420.25	-208.53	-
Dividend Per Share	-	-	-	-	-	0.498	-	-	-	-
Gross Margin	100.00%	100.00%	100.00%	100.00%	100.00%	100.00%	100.00%	100.00%	100.00%	100.00%
Operating Margin	-25441.33%	-24457.53%	-23044.07%	-8118.63%	21.17%	-264.21%	-52.37%	-600.99%	-289.75%	-1234.45%
Profit Margin	-26082.67%	-24942.47%	-23528.81%	-8111.76%	21.39%	-260.69%	-52.49%	-611.20%	-289.75%	-1177.09%
Free Cash Flow Margin	-24017.33%	-21797.26%	-22123.73%	-7479.41%	35.99%	-221.16%	-78.18%	-506.91%	-256.72%	-1555.69%
EBITDA	-19.15	-17.78	-13.45	-7.96	2.77	-8.11	-3.97	-17.27	-8.02	-5.22
EBITDA Margin	-25530.67%	-24361.64%	-22800.00%	-7805.88%	22.68%	-260.69%	-52.49%	-611.20%	-289.75%	-1253.01%
Depreciation & Amortization	0.38	0.39	0.42	0.37	0.16	0	0	0	0	0
EBIT	-19.53	-18.18	-13.88	-8.34	2.61	-8.11	-3.97	-17.27	-8.02	-5.22
EBIT Margin	-26038.67%	-24898.63%	-23518.64%	-8172.55%	21.39%	-260.69%	-52.49%	-611.20%	-289.75%	-1253.01%

Source: Financials are provided by Nasdaq Data Link and sourced from audited reports submitted to the Securities and Exchange Commission (SEC).